Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the proportion of patients indicating an overall preference for either the subcutaneous (SC) or the intravenous (IV) route of administration
Critère d'inclusion
- HER2-positive early breast cancer